119 related articles for article (PubMed ID: 29939510)
21. Impact of a chronic pain management pathway on opioid administration and prescribing in an Emergency Department.
Pace C; Shah S; Zhang AX; Zosel AE
Clin Toxicol (Phila); 2018 Aug; 56(8):744-750. PubMed ID: 29168404
[TBL] [Abstract][Full Text] [Related]
22. Long-term opioid therapy for chronic non-cancer pain in Germany.
Marschall U; L'hoest H; Radbruch L; Häuser W
Eur J Pain; 2016 May; 20(5):767-76. PubMed ID: 26492066
[TBL] [Abstract][Full Text] [Related]
23. Impact of Prior Therapeutic Opioid Use by Emergency Department Providers on Opioid Prescribing Decisions.
Pomerleau AC; Perrone J; Hoppe JA; Salzman M; Weiss PS; Nelson LS
West J Emerg Med; 2016 Nov; 17(6):791-797. PubMed ID: 27833690
[TBL] [Abstract][Full Text] [Related]
24. Physicians' beliefs and likelihood of prescribing opioid tamper-resistant formulations for chronic noncancer pain patients.
Turk DC; Dansie EJ; Wilson HD; Moskovitz B; Kim M
Pain Med; 2014 Apr; 15(4):625-36. PubMed ID: 24612185
[TBL] [Abstract][Full Text] [Related]
25. Primary care providers' views on chronic pain management among high-risk patients in safety net settings.
Vijayaraghavan M; Penko J; Guzman D; Miaskowski C; Kushel MB
Pain Med; 2012 Sep; 13(9):1141-8. PubMed ID: 22846057
[TBL] [Abstract][Full Text] [Related]
26. Opioid prescribing for chronic pain in a community-based healthcare system.
Romanelli RJ; Ikeda LI; Lynch B; Craig T; Cappelleri JC; Jukes T; Ishisaka DY
Am J Manag Care; 2017 May; 23(5):e138-e145. PubMed ID: 28810129
[TBL] [Abstract][Full Text] [Related]
27. Impact of an Opioid Prescribing Guideline in the Acute Care Setting.
del Portal DA; Healy ME; Satz WA; McNamara RM
J Emerg Med; 2016 Jan; 50(1):21-7. PubMed ID: 26281819
[TBL] [Abstract][Full Text] [Related]
28. Opioid Prescribing Practices for Pediatric Headache.
Meckler GD; Sheridan DC; Charlesworth CJ; Lupulescu-Mann N; Kim H; Sun BC
J Pediatr; 2019 Jan; 204():240-244.e2. PubMed ID: 30274923
[TBL] [Abstract][Full Text] [Related]
29. The opioid epidemic in acute care surgery-Characteristics of overprescribing following laparoscopic cholecystectomy.
Hanson KT; Thiels CA; Polites SF; Gazelka HM; Ray-Zack MD; Zielinski MD; Habermann EB
J Trauma Acute Care Surg; 2018 Jul; 85(1):62-70. PubMed ID: 29462081
[TBL] [Abstract][Full Text] [Related]
30. Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.
Mordecai L; Reynolds C; Donaldson LJ; de C Williams AC
Br J Gen Pract; 2018 Mar; 68(668):e225-e233. PubMed ID: 29440012
[TBL] [Abstract][Full Text] [Related]
31. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment.
Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):587-591. PubMed ID: 28101968
[TBL] [Abstract][Full Text] [Related]
32. Determinants of Opioid Prescribing for Nonmalignant Chronic Pain in US Outpatient Settings.
Rasu RS; Knell ME
Pain Med; 2018 Mar; 19(3):524-532. PubMed ID: 28340230
[TBL] [Abstract][Full Text] [Related]
33. Patient and provider characteristics associated with communication about opioids: An observational study.
Shields CG; Fuzzell LN; Christ SL; Matthias MS
Patient Educ Couns; 2019 May; 102(5):888-894. PubMed ID: 30552013
[TBL] [Abstract][Full Text] [Related]
34. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
35. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety.
Cox N; Tak CR; Cochella SE; Leishman E; Gunning K
J Am Board Fam Med; 2018; 31(1):105-112. PubMed ID: 29330245
[TBL] [Abstract][Full Text] [Related]
36. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers.
Starrels JL; Peyser D; Haughton L; Fox A; Merlin JS; Arnsten JH; Cunningham CO
Subst Abus; 2016; 37(1):148-53. PubMed ID: 26860130
[TBL] [Abstract][Full Text] [Related]
37. Novel peer review method for improving controlled substance prescribing in primary care.
Penti B; Liebschutz JM; Kopcza B; Xuan Z; Odell C; Saper R
J Opioid Manag; 2016; 12(4):269-79. PubMed ID: 27575828
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population.
Patel S; Carmichael JM; Taylor JM; Bounthavong M; Higgins DT
Ann Pharmacother; 2018 Apr; 52(4):325-331. PubMed ID: 29086587
[TBL] [Abstract][Full Text] [Related]
39. Effect of opioid prescribing guidelines in primary care.
Chen JH; Hom J; Richman I; Asch SM; Podchiyska T; Johansen NA
Medicine (Baltimore); 2016 Aug; 95(35):e4760. PubMed ID: 27583928
[TBL] [Abstract][Full Text] [Related]
40. Attitudes, Beliefs, Practices, and Concerns Among Clinicians Prescribing Opioids in a Large Academic Institution.
Ebbert JO; Philpot LM; Clements CM; Lovely JK; Nicholson WT; Jenkins SM; Lamer TJ; Gazelka HM
Pain Med; 2018 Sep; 19(9):1790-1798. PubMed ID: 29177439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]